Market Overview The global oral transmucosal drugs market  was valued at USD 46.48 billion in 2023 and is projected to reach USD 87.86 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% during the forecast period. Oral transmucosal drugs offer a unique method of drug delivery where active ingredients are absorbed through the mucous membranes in the mouth,...